Pulmonary Hypertension and Hyperglycemia—Not a Sweet Combination
Open Access
- 28 May 2024
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 14 (11) , 1119
Abstract
Hyperglycemia and pulmonary hypertension (PH) share common pathological pathways that lead to vascular dysfunction and resultant cardiovascular complications. These shared pathologic pathways involve endothelial dysfunction, inflammation, oxidative stress, and hormonal imbalances. Individuals with hyperglycemia or pulmonary hypertension also possess shared clinical factors that contribute to increased morbidity from both diseases. This review aims to explore the relationship between PH and hyperglycemia, highlighting the mechanisms underlying their association and discussing the clinical implications. Understanding these common pathologic and clinical factors will enable early detection for those at-risk for complications from both diseases, paving the way for improved research and targeted therapeutics.Keywords
This publication has 60 references indexed in Scilit:
- Pathogenic Mechanisms of Pulmonary Arterial HypertensionJACC: Asia, 2022
- Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysisThe Journal of Heart and Lung Transplantation, 2022
- Vascular Metabolic Mechanisms of Pulmonary HypertensionCurrent Medical Science, 2020
- TNF-α pathway and T-cell immunity are activated early during the development of diabetic nephropathy in Type II Diabetes MellitusClinical Immunology, 2020
- Associations of Mitochondrial and Nuclear Mitochondrial Variants and Genes with Seven Metabolic TraitsThe American Journal of Human Genetics, 2019
- Association Between BMI and Obesity With Survival in Pulmonary Arterial HypertensionChest, 2018
- Mitochondrial DNA Variation in Human Radiation and DiseaseCell, 2015
- BMPR2 Preserves Mitochondrial Function and DNA during Reoxygenation to Promote Endothelial Cell Survival and Reverse Pulmonary HypertensionCell Metabolism, 2015
- Hypoxia downregulates PPARγ via an ERK1/2–NF-κB–Nox4-dependent mechanism in human pulmonary artery smooth muscle cellsFree Radical Biology and Medicine, 2013
- Endothelial Cell Energy Metabolism, Proliferation, and Apoptosis in Pulmonary Hypertension2010